N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: Case reports and methods for detection

Ko Tsutsui, Takashi Kanbayashi, Manabu Takaki, Yuki Omori, Yumiko Imai, Seiji Nishino, Keiko Tanaka, Tetsuo Shimizu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The symptoms of catatonia have been reported to be similar to the initial symptoms of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed by many psychiatrists. For a differential diagnosis of catatonic state, it is important to detect anti-NMDAR encephalitis. This encephalitis is expected to be in remission by early detection and treatment. We should be more cautious about catatonic symptoms of schizophrenia. When a patient is suspected of having encephalitis, we should screen for anti-NMDAR antibodies in cerebrospinal fluid samples using a cell-based assay. We describe the methods of NMDAR antibody detection and the etiology of this encephalitis with case reports. Two representative cases with catatonia and non-catatonia (brief psychotic disorder) were reported. Schizophrenia is a general, heterogeneous, and complicated disorder, and its pathophysiology is unknown. There is an established evidence of NMDAR hypofunction, which is the functional disconnection of the central component; this is one of the most recognized models for schizophrenia. Furthermore, it is said that autoimmune mechanisms have been involved, at least in subgroups of schizophrenia patients. Further study of anti-NMDAR antibody and its related encephalitis would give essential clues for the research of schizophrenia, catatonia, and atypical psychosis.

Original languageEnglish
Pages (from-to)339-345
Number of pages7
JournalNeuropsychiatric Disease and Treatment
Volume13
DOIs
Publication statusPublished - Feb 8 2017

Fingerprint

Encephalitis
Catatonia
N-Methyl-D-Aspartate Receptors
Psychiatry
Schizophrenia
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Antibodies
Psychotic Disorders
Catatonic Schizophrenia
Cerebrospinal Fluid
Differential Diagnosis
Research
Therapeutics

Keywords

  • Antibody
  • Catatonia
  • Encephalitis
  • NMDA receptor
  • Psychosis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients : Case reports and methods for detection. / Tsutsui, Ko; Kanbayashi, Takashi; Takaki, Manabu; Omori, Yuki; Imai, Yumiko; Nishino, Seiji; Tanaka, Keiko; Shimizu, Tetsuo.

In: Neuropsychiatric Disease and Treatment, Vol. 13, 08.02.2017, p. 339-345.

Research output: Contribution to journalArticle

Tsutsui, Ko ; Kanbayashi, Takashi ; Takaki, Manabu ; Omori, Yuki ; Imai, Yumiko ; Nishino, Seiji ; Tanaka, Keiko ; Shimizu, Tetsuo. / N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients : Case reports and methods for detection. In: Neuropsychiatric Disease and Treatment. 2017 ; Vol. 13. pp. 339-345.
@article{8dd60e550f694c9abe676c09503908c1,
title = "N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: Case reports and methods for detection",
abstract = "The symptoms of catatonia have been reported to be similar to the initial symptoms of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed by many psychiatrists. For a differential diagnosis of catatonic state, it is important to detect anti-NMDAR encephalitis. This encephalitis is expected to be in remission by early detection and treatment. We should be more cautious about catatonic symptoms of schizophrenia. When a patient is suspected of having encephalitis, we should screen for anti-NMDAR antibodies in cerebrospinal fluid samples using a cell-based assay. We describe the methods of NMDAR antibody detection and the etiology of this encephalitis with case reports. Two representative cases with catatonia and non-catatonia (brief psychotic disorder) were reported. Schizophrenia is a general, heterogeneous, and complicated disorder, and its pathophysiology is unknown. There is an established evidence of NMDAR hypofunction, which is the functional disconnection of the central component; this is one of the most recognized models for schizophrenia. Furthermore, it is said that autoimmune mechanisms have been involved, at least in subgroups of schizophrenia patients. Further study of anti-NMDAR antibody and its related encephalitis would give essential clues for the research of schizophrenia, catatonia, and atypical psychosis.",
keywords = "Antibody, Catatonia, Encephalitis, NMDA receptor, Psychosis",
author = "Ko Tsutsui and Takashi Kanbayashi and Manabu Takaki and Yuki Omori and Yumiko Imai and Seiji Nishino and Keiko Tanaka and Tetsuo Shimizu",
year = "2017",
month = "2",
day = "8",
doi = "10.2147/NDT.S125800",
language = "English",
volume = "13",
pages = "339--345",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients

T2 - Case reports and methods for detection

AU - Tsutsui, Ko

AU - Kanbayashi, Takashi

AU - Takaki, Manabu

AU - Omori, Yuki

AU - Imai, Yumiko

AU - Nishino, Seiji

AU - Tanaka, Keiko

AU - Shimizu, Tetsuo

PY - 2017/2/8

Y1 - 2017/2/8

N2 - The symptoms of catatonia have been reported to be similar to the initial symptoms of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed by many psychiatrists. For a differential diagnosis of catatonic state, it is important to detect anti-NMDAR encephalitis. This encephalitis is expected to be in remission by early detection and treatment. We should be more cautious about catatonic symptoms of schizophrenia. When a patient is suspected of having encephalitis, we should screen for anti-NMDAR antibodies in cerebrospinal fluid samples using a cell-based assay. We describe the methods of NMDAR antibody detection and the etiology of this encephalitis with case reports. Two representative cases with catatonia and non-catatonia (brief psychotic disorder) were reported. Schizophrenia is a general, heterogeneous, and complicated disorder, and its pathophysiology is unknown. There is an established evidence of NMDAR hypofunction, which is the functional disconnection of the central component; this is one of the most recognized models for schizophrenia. Furthermore, it is said that autoimmune mechanisms have been involved, at least in subgroups of schizophrenia patients. Further study of anti-NMDAR antibody and its related encephalitis would give essential clues for the research of schizophrenia, catatonia, and atypical psychosis.

AB - The symptoms of catatonia have been reported to be similar to the initial symptoms of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed by many psychiatrists. For a differential diagnosis of catatonic state, it is important to detect anti-NMDAR encephalitis. This encephalitis is expected to be in remission by early detection and treatment. We should be more cautious about catatonic symptoms of schizophrenia. When a patient is suspected of having encephalitis, we should screen for anti-NMDAR antibodies in cerebrospinal fluid samples using a cell-based assay. We describe the methods of NMDAR antibody detection and the etiology of this encephalitis with case reports. Two representative cases with catatonia and non-catatonia (brief psychotic disorder) were reported. Schizophrenia is a general, heterogeneous, and complicated disorder, and its pathophysiology is unknown. There is an established evidence of NMDAR hypofunction, which is the functional disconnection of the central component; this is one of the most recognized models for schizophrenia. Furthermore, it is said that autoimmune mechanisms have been involved, at least in subgroups of schizophrenia patients. Further study of anti-NMDAR antibody and its related encephalitis would give essential clues for the research of schizophrenia, catatonia, and atypical psychosis.

KW - Antibody

KW - Catatonia

KW - Encephalitis

KW - NMDA receptor

KW - Psychosis

UR - http://www.scopus.com/inward/record.url?scp=85012055037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012055037&partnerID=8YFLogxK

U2 - 10.2147/NDT.S125800

DO - 10.2147/NDT.S125800

M3 - Article

AN - SCOPUS:85012055037

VL - 13

SP - 339

EP - 345

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -